[1] Yang D,Wang J, Ni J, et al. Temporal expression of metalloproteinase-8 and-13 and their relationships with extracellular matrix metalloproteinase inducer in the development of ligature-induced periodontitis in rats [J]. Journal of periodontal research, 2013, 48(4)∶411-419 [2] Xiong L, Edwards C K, Zhou L. The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature [J]. International journal of molecular sciences, 2014, 15(10)∶17411-17441 [3] Zhu X, Song Z, Zhang S, et al. CD147: A Novel Modulator of Inflammatory and Immune Disorders [J]. Current medicinal chemistry, 2014, 21(19)∶2138-2145 [4] Wang P,Heitman J. The cyclophilins [J]. Genome Biol, 2005, 6(2)∶226-230 [5] Sun S, Guo M, Zhang JB, et al. Cyclophilin A (CypA) interacts with NF-kappaB subunit,p65/RelA, and contributes to NF-kappaB activation signaling [J]. PLoS One, 2014, 9(8)∶e96211 [6] Obchoei S, Sawanyawisuth K, Wongkham C, et al. Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway [J]. Tumor Biology, 2014∶1-11 [7] Seizer P, Gawaz M, May A E. Cyclophilin A and EMMPRIN (CD147) in cardiovascular diseases [J]. Cardiovascular research, 2014, 102(1)∶17-23 [8] Yuan W, Ge H, He B. Pro-inflammatory activities induced by CyPA–EMMPRIN interaction in monocytes [J]. Atherosclerosis, 2010, 213(2)∶415-421 [9] V. Yurchenko, S. Constant, M. Bukrinsky, Dealing with the family: CD147 interactions with cyclophilins [J]. Immunology, 2006, 117(3)∶301-309 [10] Nishioku T, Dohgu S, Koga M, et al. Cyclophilin A secreted from fibroblast-like synoviocytes is involved in the induction of CD147 expression in macrophages of mice with collagen-induced arthritis [J]. J Inflamm (Lond), 2012, 9(1)∶44-44 [11] Liu L, Li C, Cai C, et al. Cyclophilin A (CypA) is associated with the inflammatory infiltration and alveolar bone destruction in an experimental periodontitis [J]. Biochemical and biophysical research communications, 2010, 391(1)∶1000-1006 [12] Seizer P, Ochmann C, Schnberger T, et al. Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion [J]. Arteriosclerosis, thrombosis, and vascular biology, 2011, 31(6)∶1377-1386 [13] Seizer P, Schnberger T, Schtt M, et al. EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation [J]. Atherosclerosis, 2010, 209(1)∶51-57 [14] Seizer P, Geisler T, Bigalke B, et al. EMMPRIN and its ligand Cyclophilin A as novel diagnostic markers in inflammatory cardiomyopathy [J]. International journal of cardiology, 2013, 163(3)∶299-304 [15] Yang Y, Lu N, Zhou J, et al. Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis [J]. Rheumatology, 2008, 47(9)∶1299-1310 [16] 王艳青,胡菊花,李颂,等.亲环素A在人根尖周炎中的表达与临床表现的相关性研究[J].牙体牙髓牙周病学杂志,2015,25(1)∶73-78 [17] 鄢雪川, 陈德平, 宿玉成.CBCT 和根尖放射线片诊断根尖周炎的对比性研究[J].口腔医学研究,2014,30(5)∶461-464 [18] Li M, Zhai Q, Bharadwaj U, et al. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147 [J]. Cancer, 2006, 106(10)∶2284-2294 [19] Sousa NGK, Cardoso CRB, Silva JS, et al. Association of matrix metalloproteinase inducer (EMMPRIN) with the expression of matrix metalloproteinases-1,-2 and-9 during periapical lesion development [J]. Archives of Oral Biology, 2014∶944-953 [20] Liu L, Li C, Cai X, et al. The temporal expression and localization of extracellular matrix metalloproteinase inducer (EMMPRIN) during the development of periodontitis in an animal model [J]. Journal of periodontal research, 2010, 45(4)∶541-549 [21] Omi Y, Shibata N, Okamoto T, et al. The role of CD147 in the invasiveness of follicular thyroid carcinoma cells [J]. Thyroid, 2012, 22(4)∶383-394 [22] Kim H, Kim WJ, Jeon ST, et al. Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages [J]. Clinical Immunology, 2005, 116(3)∶217-224 |